Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile
- 1 October 1993
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 14 (10) , 366-376
- https://doi.org/10.1016/0165-6147(93)90095-2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Thrombin receptor expression in normal and atherosclerotic human arteries.Journal of Clinical Investigation, 1992
- Vascular Effects of ThrombinSeminars in Thrombosis and Hemostasis, 1992
- A Role for α-Thrombin in Polymorphonuclear Leukocyte Recruitment During InflammationSeminars in Thrombosis and Hemostasis, 1992
- Thrombin-Mediated Increase in Vascular Endothelial PermeabilitySeminars in Thrombosis and Hemostasis, 1992
- Pharmacology of Synthetic Thrombin Inhibitors of the Tripeptide TypeCardiovascular Drug Reviews, 1992
- The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplastyJournal of the American College of Cardiology, 1991
- Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart.Circulation Research, 1991
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.Circulation, 1991
- Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.Circulation, 1989